Literature DB >> 2002552

Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual.

M Groenink1, R A Fouchier, R E de Goede, F de Wolf, R A Gruters, H T Cuypers, H G Huisman, M Tersmette.   

Abstract

Previously, we and others have demonstrated a relation between the clinical course of human immunodeficiency virus type 1 (HIV-1) infection and biological properties of HIV-1 variants such as replication rate, syncytium-inducing (SI) capacity, and cytotropism. For the molecular analysis of the biological variability in these properties, we generated a panel of phenotypically distinct yet genetically highly homologous infectious molecular clones. These clones were derived from HIV-1 isolates, mostly recovered by direct clonal isolation, from a single individual in whom a transition from non-SI to SI isolates had been identified over time. Of 17 molecular clones tested, 8 were infectious. The clones exhibited differences in SI capacity and T-cell line tropism. Their phenotypes corresponded to those of their parental isolates, formally demonstrating that biological variability of HIV-1 isolates can be attributed to single molecular clones. With these clones we demonstrated that SI capacity and tropism for the H9 T-cell line, almost invariably coupled in primary HIV-1 isolates, are discernible properties. Also different requirements appeared to exist for H9 and Sup T1 cell line tropism. We obtained evidence that T-cell line tropism is not caused by differences in level of HIV-1 expression but most probably is restricted at the level of virus entry. Restriction mapping of four clones with divergent phenotypes revealed a high degree of nucleotide sequence homology (over 96.3%), indicating the usefulness of these clones for the tracking of genetic variability critical for differences in biological phenotype.

Entities:  

Mesh:

Year:  1991        PMID: 2002552      PMCID: PMC240031     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Authors:  A Meyerhans; R Cheynier; J Albert; M Seth; S Kwok; J Sninsky; L Morfeldt-Månson; B Asjö; S Wain-Hobson
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

2.  Reversal of HIV-phenotype to fulminant replication on macrophages in perinatal transmission.

Authors:  H Rübsamen-Waigmann; W R Willems; U Bertram; H von Briesen
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Continuous clearance of HIV in a vertically infected child.

Authors:  A Baur; N Schwarz; S Ellinger; K Korn; T Harrer; K Mang; G Jahn
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.

Authors:  J Sodroski; W C Goh; C Rosen; K Campbell; W A Haseltine
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

5.  Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

Authors:  M Alizon; S Wain-Hobson; L Montagnier; P Sonigo
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

6.  Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

Authors:  B Asjö; L Morfeldt-Månson; J Albert; G Biberfeld; A Karlsson; K Lidman; E M Fenyö
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

7.  Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression.

Authors:  M Green; M Ishino; P M Loewenstein
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

8.  A highly sensitive, mixed-phase assay for chloramphenicol acetyltransferase activity in transfected cells.

Authors:  D A Nielsen; T C Chang; D J Shapiro
Journal:  Anal Biochem       Date:  1989-05-15       Impact factor: 3.365

9.  Use of unpurified synthetic deoxynucleotide primers for rapid dideoxynucleotide chain termination sequencing.

Authors:  R Sanchez-Pescador; M S Urdea
Journal:  DNA       Date:  1984-08

10.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

Authors:  J Goudsmit; F de Wolf; D A Paul; L G Epstein; J M Lange; W J Krone; H Speelman; E C Wolters; J Van der Noordaa; J M Oleske
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

View more
  28 in total

1.  High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus.

Authors:  J C de la Torre; C Giachetti; B L Semler; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Continued utilization of CCR5 coreceptor by a newly derived T-cell line-adapted isolate of human immunodeficiency virus type 1.

Authors:  K E Follis; M Trahey; R A LaCasse; J H Nunberg
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.

Authors:  G Alkhatib; C C Broder; E A Berger
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 4.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period.

Authors:  V V Lukashov; C L Kuiken; J Goudsmit
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants.

Authors:  A Carrillo; L Ratner
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle.

Authors:  R A Fouchier; M Brouwer; N A Kootstra; H G Huisman; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

Authors:  A B van't Wout; N A Kootstra; G A Mulder-Kampinga; N Albrecht-van Lent; H J Scherpbier; J Veenstra; K Boer; R A Coutinho; F Miedema; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.

Authors:  M Groenink; A C Andeweg; R A Fouchier; S Broersen; R C van der Jagt; H Schuitemaker; R E de Goede; M L Bosch; H G Huisman; M Tersmette
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques.

Authors:  Janet M Harouse; Clarisa Buckner; Agegnehu Gettie; Ross Fuller; Rudolf Bohm; James Blanchard; Cecilia Cheng-Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.